Pharmaceutical giant Pfizer has prepared the first shipments of its COVID-19 oral antiviral pill, which “significantly” reduces the risk of hospitalization and death for high-risk patients, and sent them to the airport for distribution across Europe and America pending approval, it announced Tuesday.
“Thrilled to see the first shipments of our COVID-19 antiviral candidate head to the airport for distribution across Europe and the United States,” the company wrote on Twitter. “Approval or authorization could be a big step forward in helping end this pandemic.”
